October 17, 2016

Dr. Ian Mortimer and Matthew Page give a brief overview of the strategies, discuss the most recent quarter’s performance and share their outlook for 2016.

https://vimeo.com/189038755/918e819930

Click Here for a pdf version of the webcast slides.

For your convenience, we have summarized highlights from the call in the notes below:

  • In the third quarter of 2016, the Guinness Atkinson Dividend Builders Fund, ticker GAINX, underperformed its benchmark rising 4.33% vs. the MSCI World Index, which was up 4.99%. 
  • There were no changes in the portfolio during the quarter
  • During the quarter the top 5 performers were Largan Precision, Schneider Electric, Illinois Tool Works, WPP and Microsoft
  • The bottom 5 performers were Teva Pharmaceutical, Royal Dutch Shell, Coca Cola, Deutsche Boerse and Imperial Brands
Performance YTD 1-Year 3-Year 5-Year 10-Year Since Inception
Dividend  Builder Fund 9.38% 14.05% 5.95% n/a n/a 9.55% 
MSCI World Index  6.06%   12.04% 6.48% n/a n/a 9.16% 

 

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Fund may be lower or higher than the performance quoted. For performance current to the most recent month end please visit, https://www.gafunds.com. Total returns reflect a fee waiver in effect and in the absence of this waiver, the total returns would be lower. Index performance is not illustrative of fund performance. One cannot invest directly in an index. 

 Opinions expressed are subject to change at any time, are not guaranteed and should not be considered investment advice. 
 

 Click Here to view Fund holdings.

 Fund holdings and sector allocations are subject to change and are not recommendations to buy or sell any security. 

Earnings growth is not representative of the Fund’s future performance. 


FOR INSTITUTIONAL USE ONLY